Therapeutic Induction of Dermal Remodeling in Veterans to Prevent Actinic Neoplasia Caused by Chronic Environmental Exposure to Ultraviolet Radiation
The investigators' previous studies demonstrate geriatric subject skin responds differently to ultraviolet B (UVB) light compared to young subject skin, which contribute to increased rates of nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) development in geriatric populations. Previously, the investigators have shown that therapeutic dermal remodeling interventions (e.g., fractionated laser resurfacing and microneedling) can restore appropriate skin responses to UVB in geriatric skin. The investigators also demonstrated fractionated laser resurfacing (FLR) reduced rates of NMSC and AK development (compared to untreated control skin) in at risk geriatric subjects.
This interventional study will assess the ability of two therapeutic dermal remodeling therapies, microneedling and trichloroacetic acid chemical (TCA) peel, to impact NMSC and AK development in at risk geriatric subjects. Geriatric subjects will be enrolled into one of two study groups. In the first group, one arm will be treated with microneedling and the other arm will not be treated on day 1. In the second group, one arm will be treated with TCA peel and the other arm will not be treated on day 1. Subjects will subsequently be monitored for number of NMSC and AK on treated and untreated (control) forearms in each group. In addition to monitoring NMSC and AK development, subjects at the Richard L. Roudebush VAMC will undergo skin punch biopsy at one of their follow up visits for microscopic and molecular analyses of treated and untreated skin.
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Matthew J Turner, MD
- Telefoonnummer: (317) 988-5000
- E-mail: matthew.turner@va.gov
Studie Locaties
-
-
Indiana
-
Indianapolis, Indiana, Verenigde Staten, 46202-2884
- Richard L. Roudebush VA Medical Center, Indianapolis, IN
-
Contact:
- Matthew J Turner, MD
- Telefoonnummer: 317-988-5000
- E-mail: matthew.turner@va.gov
-
Hoofdonderzoeker:
- Matthew J Turner, MD
-
-
Ohio
-
Dayton, Ohio, Verenigde Staten, 45428
- Dayton VA Medical Center, Dayton, OH
-
Contact:
- Jeffrey B Travers, MD
- E-mail: jeffrey.travers@va.gov
-
Contact:
- Craig A Rohan, MD
- E-mail: craig.rohan@va.gov
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Adult Males and Females age 60 and older with 5 or more AKs on each forearm
- Skin type fair-Fitzpatrick I-II
- Able to comprehend procedures and risks
Exclusion Criteria:
- More than 10 AKs on an extremity, or AKs that are large (2-3+)
- Medical history of Diabetes
- Coagulopathy or easy bleeding
- History of poor wound healing or scarring
- Large tattoos that can interfere with study
- Other serious health issues and other skin diseases that could interfere with the study
- Recent (within 1 year) field therapies such as Efudex cream or PDT to forearms
- Planning to leave region in next 4 years
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Microneedling - Male
Forearm treatment with microneedling
|
Microneedling- a mechanical tool that makes tiny holes in a superficial part of the skin
|
|
Experimenteel: Microneedling - Female
Forearm treatment with microneedling
|
Microneedling- a mechanical tool that makes tiny holes in a superficial part of the skin
|
|
Experimenteel: Trichloroacetic acid peel - Male
Forearm treatment with trichloroacetic acid peel
|
Trichloroacetic acid peel that removes a superficial part of the skin
|
|
Experimenteel: Trichloroacetic acid peel - Female
Forearm treatment with trichloroacetic acid peel
|
Trichloroacetic acid peel that removes a superficial part of the skin
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change From Baseline in the Number of Actinic Keratosis due to treatment.
Tijdsspanne: up to 4 years
|
Investigator will assess the number of actinic keratosis on both forearms
|
up to 4 years
|
|
Change From Baseline in the Number Non-Melanoma Skin Cancers due to treatment.
Tijdsspanne: up to 4 years
|
Investigator will assess the number of nonmelanoma skin cancers on both forearms.
|
up to 4 years
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Matthew J Turner, MD, Richard L. Roudebush VA Medical Center, Indianapolis, IN
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- ONCE-003-25S
- RD001084 (Ander subsidie-/financieringsnummer: U.S. Veterans Administration)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .